Extendicare Inc's stock is on the rise, reflecting strong market sentiment and strategic growth initiatives.
In the latest trading session, Extendicare Inc (EXE.TO) saw its stock price increase by 1.30%, closing at CA$34.24. This uptick is a positive sign for investors, indicating confidence in the company's future prospects amidst its recent strategic moves.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Extendicare Inc
EXE.TO
EXE.TO
Extendicare Inc
WealthAwesomeMarket cap
$3.51B
P/E
27.2x
52W high
$37.59
52W low
$11.86
1W change
+0.27%
Beta
1.15
Analyst Price Targets
Based on analyst covering EXE
Wall Street analysts forecast EXE stock price to rise 3.2% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$38.28
+3.2% Upside
Current Price
C$37.10
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EXE's historical volatility
30-Day Vol
25.2%
Annualized
90-Day Vol
33.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$44.35
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$39.38 | C$36.10 โ C$42.95 |
| 60 trading days | C$41.79 | C$36.96 โ C$47.25 |
| 90 trading days | C$44.35 | C$38.16 โ C$51.55 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: The recent gains in Extendicare's stock highlight the company's robust performance and strategic acquisitions that are likely to enhance its market position.
1.30% Gain in One Day
Extendicare's stock rose by 1.30% in the last trading session, reflecting positive investor sentiment and confidence in its growth strategies.
Bull case
Extendicare's recent acquisition of CBI Home Health for $570 million is expected to significantly boost its home health care services, contributing to long-term growth. The company's strong Q1 2026 financial performance, with a 52.2% increase in adjusted EBITDA, shows its operational strength and boosts market confidence.
Bear case
Despite the positive performance, investors should stay cautious. The healthcare sector is competitive, and any regulatory changes or economic downturns could affect profitability and stock performance.
Strategic Acquisitions Fuel Growth
Extendicare's recent acquisition of CBI Home Health is a pivotal move aimed at enhancing its service offerings in the home health care sector. This acquisition not only expands its market reach but also aligns with the growing demand for home health services, positioning the company for sustainable growth in the coming years.
Strong Financial Performance
The company's financial results for Q1 2026 showcased a remarkable 52.2% increase in adjusted EBITDA, driven by organic growth and strategic initiatives. This strong performance underlines Extendicare's operational efficiency and its ability to capitalize on market opportunities, further boosting investor confidence.
Dividend Increase Signals Confidence
In a show of confidence in its financial health, Extendicare announced a 5% increase in its monthly dividend. This move not only rewards shareholders but also reflects the company's commitment to returning value while pursuing growth strategies, making it an attractive option for income-focused investors.
Advertisement
